Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
7057669
Reference Type
Journal Article
Title
Quinones as preventive agents in Alzheimer's diseases: focus on NLRP3 inflammasomes
Author(s)
Chen, Dabao; Gao, Huawu; Peng, C; Pei, SQ; Dai, Anran; Yu, XueT; Zhou, P; Wang, Yan; Cai, B; ,
Year
2020
Is Peer Reviewed?
Yes
Journal
Journal of Pharmacy and Pharmacology
ISSN:
0022-3573
Publisher
WILEY
Location
HOBOKEN
Page Numbers
1481-1490
PMID
32667050
DOI
10.1111/jphp.13332
Web of Science Id
WOS:000548432800001
Abstract
Objectives Alzheimer's disease (AD) is a hidden neurological degenerative disease, which main clinical manifestations are cognitive dysfunction, memory impairment and mental disorders. Neuroinflammation is considered as a basic response of the central nervous system. NLRP3 (Nucleotide-binding domain leucine-rich repeat (NLR) and pyrin domain containing receptor 3) inflammasome is closely related to the occurrence of neuroinflammation. Activation of the NLRP3 inflammasome results in the release of cytokines, pore formation and ultimately pyroptosis, which has demonstrated one of the critical roles in AD pathogenesis. Inhibition of the activity of NLRP3 is one of the focuses of the research. Therefore, NLRP3 represents an attractive pharmacological target, and discovery compounds with good NLRP3 inhibitory activity are particularly important. Key findings Quinones have good neuroprotective effects and prevent AD, which may be related to their regulation of inflammatory response. The molecular docking was used to explore 12 quinones with AD prevention and treatment and NLRP3. Docking results showed that the combination of anthraquinones and NLRP3 were the best, and the top two chemical compounds were Purpurin and Rhein, which are the most promising NLRP3 inhibitors. These quinones may provide the theoretical basis for finding lead compounds for novel neuroprotective agents.
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity